Press Releases

Clinical ink Announces New Continuous Glucose Monitoring Solution

Clinical Ink, a global life science technology company, now offers continuous glucose monitoring (CGM) within its integrated digital biomarker solution. The new modules enable remote collection, central storage, and analysis of sensor data from commercially available devices for use in diabetes clinical trials. The solution addresses device connectivity status, providing robust, on-device CGM data collection in both offline and online scenarios with efficient data synchronization management when connected. This integration is facilitated by the recent FDA clearance of commercial CGM devices, which include the Abbott FreeStyle...

RCT-DUPLICATE Findings Demonstrate Capability of Real-World Evidence Studies to Reach Conclusions Similar to Randomized Clinical Trials

Real-world evidence (RWE) technology and analytics company Aetion has announced the culmination of the RCT-DUPLICATE demonstration project, with complete findings published in The Journal of the American Medical Association (JAMA). This three-year initiative tested whether researchers asking clinical questions in real-world data (RWD)—data from patients’ day-to-day interactions with the healthcare system—would obtain similar results to findings from randomized clinical trials (RCTs). In cases where clinical trial designs aligned with real patient care processes, the RWE studies and RCTs came to largely similar conclusions. As part of...

Replica Analytics unveils Replica Synthesis 3.0

Replica Analytics, an Aetion company, has released Replica Synthesis 3.0, its privacy- and utility-preserving synthetic data generation software that has been updated with an enhanced user experience. This makes it easier for analysts to train generative models and evaluate their utility and privacy. The company unveiled the latest version of its software during a Privacy Enhancing Technologies (PETs) demonstration at the Privacy Symposium, which attracts data protection experts from around the world to discuss the latest developments in data protection regulations, compliance, and innovative technologies. “There...

M2GEN Rebrands to Aster Insights

Bioinformatics company M2GEN has announced that it is rebranding, changing its name to Aster Insights. As the nexus between patients, researchers, and the life sciences industry, the company’s unique clinical and molecular dataset has enabled new insights for researchers and accelerated target identification and drug discovery. The rebrand reflects both the company’s 15-year history in oncology, genomics, and patient engagement while positioning Aster Insights as the market leader in oncology research and discovery. “Aster [is] derived from the Greek word for ‘star,’ Like the explorers and navigators...

Reimagine Care and The Center for Cancer & Blood Disorders Announce Partnership

Reimagine Care announced that it has partnered with The Center for Cancer & Blood Disorders (CCBD), one of the country’s most respected cancer centers, to offer its home-based supportive care and symptom management program to patients in the Dallas-Fort Worth area. Thousands of CCBD patients will have access to on-demand support from experienced oncology nurses and advanced practitioners via text, phone, and video, along with in-home care when appropriate. This proactive approach is designed to reduce patients’ symptom burden, improve the patient and caregiver experience, and...

Modern Healthcare Recognizes IVX Health in its 2022 Best Places to Work in Healthcare List

For the fourth consecutive year, IVX Health has been recognized by Modern Healthcare as one of the Best Places to Work in Healthcare in 2022. This annual program identifies and honors 150 outstanding companies and organizations in the healthcare industry nationwide, and IVX Health was ranked No. 20 overall in one of its two category designations. “At many of the organizations highlighted, it starts with instilling a sense of balance—and not just the general work-life balance employees crave, but the balance that comes from understanding their...

Lightship® and Acclinate Announce Partnership to Increase Access to Clinical Trials for Diverse Populations

Lightship is teaming up with digital health company Acclinate to increase access to and engagement of diverse participants in a decentralized neurology clinical trial for a large pharmaceutical company. Beyond the neurology trial, the partnership aims to increase access and engagement in clinical trials for underrepresented populations. Acclinate’s #NOWINCLUDED™ and e-DICT™ engagement and predictive analytics platform, in combination with Lightship’s tailored approach to designing and delivering clinical trials that are more accessible and offer more choice to patients in need, are being used to engage participants...

Komodo Health Appoints Lauren Stahl as Head of Sales

Komodo Health announced that Lauren Stahl has been appointed as the company’s vice president and head of sales, effective immediately. In this role, Stahl’s responsibilities include sales team leadership across Komodo’s entire portfolio of customers, overseeing operational strategy to drive business efficiencies, and year-over-year growth and market expansion. As head of sales, Stahl will oversee Komodo Heath’s entire sales organization, with responsibilities for driving business and revenue growth as Komodo scales its offerings and footprint across more than a dozen market segments. “Lauren has demonstrated an exceptional...

Augmedix Launches New Service, Augmedix Prep, to Significantly Reduce Physician Chart Prep Burden

Augmedix, a provider of automated medical documentation solutions, has announced the launch of Augmedix Prep, a new service that significantly reduces the burden on medical staff from preparing charts prior to a patient visit. The new service features specialized technology that prepares a patient note structure and content for the physician based on the unique visit type and the patient’s previous medical records. Typically, physicians need to do this before they see a patient, but with Augmedix Prep, all the provider needs to do is review...

Augmedix Reports Second Quarter 2022 Financial Results

On August 8, 2022, Augmedix reported its financial results for the three-month period that ended on June 30, 2022. Manny Krakaris, chief executive officer of Augmedix, noted that “we continued to see good momentum and are pleased with our strong start to 2022. We remain focused on our path to profitability as we drive enterprise customer expansion, make good progress on our automation and new product development, and scale our business model… As physician retention, burnout, and staffing shortages continue to impact healthcare organizations, our...